Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Silver Nanocluster DNA Probes Detect MicroRNA

By LabMedica International staff writers
Posted on 23 Oct 2012
A method that uses inexpensive technology and simple analytical apparatuses promises to trim days off the laboratory work done to diagnose diseases. More...


Any disease that assails a patient leaves genetic clues all over the victim, and because the profiles of micro ribonucleic acid (miRNA) vary by type of cancer, finding it proves beyond a reasonable doubt what is making the patient sick.

A chemist and a biologist from University of Copenhagen (Denmark) invented the detection method, which exploits a natural quality of genetic material. Together they figured out how to attach the light emitting molecules to DNA sensors for miRNA detection. When these luminous DNA-strands stick with microRNA-strands, their light is quenched, giving a very visible indication that the target miRNA is present in the sample.

A single DNA strand is made up of molecules, so called bases, ordered in a unique combination. When two strands join to form their famous double helix, they do so by sticking to complementary copies of themselves. Likewise, strands tailored to match particular miRNAs will stick to the real thing with uncanny precision.

The scientists tested their Silver Nano Cluster DNA probes with eight different types of genetic material and found that they work outright with six of them. They then fathomed how to fix the ones that did not perform. This indicates that their method will work in the detection of almost all types of miRNAs, also in all likelihood for cancer related miRNAs. The most widespread current miRNA detection method requires some 48 hours of laboratory work from raw samples. The new method can do the same job of detection within a maximum of six hours.

Tom Vosch, PhD, from the Department of Chemistry and senior coauthor of the study said, "We invented a probe that emits light only as long as the sample is clean. That is an unusually elegant and easy way to screen for a particular genetic target." The study was published on September 4, 2012, in the American Chemical Society journal ACSNano.

Related Links:

University of Copenhagen



New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Laboratory Software
ArtelWare
New
Blood Glucose Test Strip
AutoSense Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.